Josh Schimmer

Stock Analyst at Cantor Fitzgerald

(3.19)
# 475
Out of 5,441 analysts
174
Total ratings
Success rate
Average return
62 Stocks
Name Action PT Current % Upside Ratings Updated
RCKT Rocket Pharmaceutica...
Maintains: Overweight
10 8
2.93 173.04% 7 Aug 8, 2025
BBIO BridgeBio Pharma
Reiterates: Overweight
95 95
48.24 96.93% 12 Jul 29, 2025
TRVI Trevi Therapeutics
Initiates Coverage On: Overweight
25
7.33 241.06% 1 Jul 1, 2025
CMPS Compass Pathways
Downgrades: In-Line
11 6
4.33 38.57% 2 Jun 23, 2025
SEPN Septerna
Maintains: Overweight
20 25
11.5 117.39% 3 May 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
260 280
195.94 42.9% 4 May 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
75 75
23.91 213.68% 4 Apr 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
50 50
11.09 350.86% 2 Apr 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
23 20
2.55 684.31% 2 Mar 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
215
137.58 56.27% 5 Feb 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: In-Line
5 5
2.19 128.31% 4 Dec 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
200 200
22.68 781.83% 6 Dec 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
25 25
21.06 18.71% 1 Dec 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
n/a
n/a n/a 5 Dec 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 16 Oct 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
30 30
16.38 83.15% 4 Oct 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Sep 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
n/a
n/a n/a 2 Sep 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
90 90
27.39 228.59% 6 Sep 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
n/a
n/a n/a 1 Sep 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
n/a
n/a n/a 5 Sep 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
n/a
n/a n/a 1 Sep 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
n/a
n/a n/a 1 Sep 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
n/a
n/a n/a 1 Sep 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
n/a
n/a n/a 1 Sep 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
15 15
0.49 2961.22% 3 Aug 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
54 53
45.74 15.87% 5 Aug 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
65 65
34.12 90.5% 3 Aug 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
50 60
65.86 -8.9% 5 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Overweight
50 50
1.32 3687.88% 1 Jun 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: In-Line
43 5
2.67 87.27% 2 Nov 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: In-Line
40
40.39 -0.97% 1 Jun 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
20 11
1.48 643.24% 2 Jun 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: In-Line
24 15
14.74 0.07% 3 Apr 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: In-Line
2 2
n/a n/a 1 Mar 30, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: In-Line
140 130
123.99 4.85% 1 Nov 14, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: In-Line
760
546.18 39.15% 2 Oct 17, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
15
12.45 20.48% 1 Mar 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
50
15.31 226.58% 1 Aug 23, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
350
2.72 12767.65% 1 Jun 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
45
n/a n/a 1 Mar 25, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
55
7.09 675.74% 1 Feb 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
30
2.05 1363.41% 1 Dec 29, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
480
6.49 7295.99% 1 Sep 1, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
15
32.48 -53.82% 3 May 12, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: In-Line
n/a
n/a n/a 4 Dec 9, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
n/a
n/a n/a 2 Apr 12, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
n/a
n/a n/a 3 Feb 25, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
222 250
349.43 -28.45% 4 Nov 16, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
196 0
n/a n/a 2 Sep 4, 2018